Post Categories Uncategorized Post dateApril 27, 2025Post last updated dateUpdated April 27, 2025 Olutasidenib is a Mutant IDH1 Inhibitor for the Treatment of AML or MDS Post author Cholesterol Absorption InhibitorsPost read time1 min read Acute myeloid leukemia (AML) is a kind of cancer diseases, a cancer of the...